Winston Neville

Winston Neville has a diverse work experience in the finance and medical technology sectors. Winston most recently worked at GRAIL as an Associate Director, FP&A, where they began in December 2022 and currently holds the position. Prior to that, they were a Manager, FP&A at GRAIL from March 2022 to December 2022. Before joining GRAIL, Winston worked as a Senior Financial Analyst, FP&A at GRAIL from January 2021 to March 2022.

Winston also gained experience at Abbott, where they worked in Global Development Finance from November 2019 to January 2021. Additionally, Winston was a New Venture Fellow at the UCLA Technology Development Group from January 2019 to July 2019.

In the earlier stages of their career, Winston worked as a Finance and Strategy Intern at Amgen from June 2018 to September 2018. Winston also has engineering experience, having served as a Device Engineer at EBR Systems, Inc. from March 2015 to March 2017. In this role, they were responsible for guiding the development of a surgical product and training European physicians on its use in a clinical trial.

Lastly, Winston worked as an R&D Engineer at Cervel Neurotech from June 2013 to January 2015. Winston led the Product Development team in the creation of a non-pharmaceutical treatment device for Depression and supported clinical trial efforts.

Overall, Winston Neville has a strong background in finance, with experience in financial analysis, venture capital, and development finance. Winston also has expertise in medical technology, specifically in product development and clinical trial support.

Winston Neville pursued their education by first obtaining a Bachelor of Science degree from Duke University. Winston attended from 2009 to 2013 and focused on Biomedical Engineering, with a minor in Mathematics. Following their undergraduate studies, they went on to attend the UCLA Anderson School of Management from 2017 to 2019, where they completed a Master of Business Administration (MBA) degree.